N,N,N',N'-Tetrapropyl-terephthalsaeure-diamid | 14557-48-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N,N,N',N'-Tetrapropyl-terephthalsaeure-diamid
• 英文别名: 1,4-Terephthalsaeure-bis-(dipropylamid)；N,N,N',N'-tetra-n-propylterephthalamide；1-N,1-N,4-N,4-N-tetrapropylbenzene-1,4-dicarboxamide
• CAS: 14557-48-3
• 化学式: C₂₀H₃₂N₂O₂
• 分子量: 332.486
• InChiKey: UYXVJEPJWPHBQJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  24
• 可旋转键数：
  10
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  40.6
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• Perfluorinated t-amino cyclic ethers
  申请人：MINNESOTA MINING AND MANUFACTURING COMPANY

  公开号：EP0492823A2

  公开（公告）日：1992-07-01

  Perfluorinated, t-amino cyclic ethers are provided. Electrochemical fluorination of N,N-dialkyl carboxamides provides Class 1 compounds of one or a mixture of perfluorinated, N-alkyl, aliphatic-substituted, saturated 1,3-oxazolidine and perfluorinated, N-alkyl, aliphatic-substituted, saturated 1,3-oxazine. Class 2 compounds comprise one or a mixture of Class 1 compounds, as well as perfluorinated, aliphatic-substituted 2-dialkylaminotetrahydrofuran and perfluorinated, aliphatic-substituted 2-dialkylamino dihydropyran.

  提供了全氟 t-氨基环醚。N,N-二烷基羧酰胺的电化学氟化提供了第 1 类化合物，即全氟 N-烷基、脂肪族取代的饱和 1,3-恶唑烷和全氟 N-烷基、脂肪族取代的饱和 1,3-恶嗪的一种或混合物。第 2 类化合物包括第 1 类化合物的一种或混合物，以及全氟脂肪族取代的 2-二烷基氨基四氢呋喃和全氟脂肪族取代的 2-二烷基氨基二氢吡喃。
• METAL COMPLEXES AND METHODS OF TREATMENT
  申请人：Collaborative Medicinal Development, LLC

  公开号：EP3068762B1

  公开（公告）日：2019-12-25
• Metal Complexes and Methods of Treatment
  申请人：PROCYPRA THERAPEUTICS LLC

  公开号：US20160271175A1

  公开（公告）日：2016-09-22

  In one embodiment, the present application discloses compounds that are selective neuroactive agents for the treatment of diseases of the central nervous system (CNS). In one aspect, the neuroactive agents are NCDs of metal chelates, including complexes of iron, copper or zinc.
• [EN] METAL COMPLEXES AND METHODS OF TREATMENT<br/>[FR] COMPLEXES MÉTALLIQUES ET MÉTHODES DE TRAITEMENT
  申请人：COLLABORATIVE MEDICINAL DEV LLC

  公开号：WO2015070177A2

  公开（公告）日：2015-05-14

  In one embodiment, the present application discloses compounds that are selective neuroactive agents for the treatment of diseases of the central nervous system (CNS). In one aspect, the neuroactive agents are NCDs of metal chelates, including complexes of iron, copper or zinc.
• [EN] NON-COVALENT DERIVATIVES AND METHODS OF TREATMENT<br/>[FR] DÉRIVÉS NON COVALENTS ET PROCÉDÉS DE TRAITEMENT
  申请人：WARNER BABCOCK INST FOR GREEN CHEMISTRY LLC

  公开号：WO2018222572A1

  公开（公告）日：2018-12-06

  The present application discloses compositions that are NCDs of histone deacetylase inhibitors.